Migraine prevention by targeting glutamate ...(evention trial are expected in the first...),Health
Navigation Links
Migraine prevention by targeting glutamate receptors?
Date:4/28/2009
evention trial are expected in the first half of 2010.
'/>"/>
| Contact: Mike Sinclair msinclair@halsin.com 44-207-084-5955 Halsin Partners Source:Eurekalert |
Related medicine news :
1. Neuromuscular Dentistry Ends Womans Migraines
2. Migraine Tied to Thickening in Brain Area
3. Business Coalition Honors BlueChoice HealthPlan for Migraine Program
4. The HealthCentral Network Wins eHealthcare Awards for Breast Cancer and Migraine Web Sites
5. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
6. Comatose locusts may help relieve migraines
7. Epilepsy Drug Doesnt Prevent Migraines
8. MyMigraineConnection.com and Migraine Expert Teri Robert Announce Seventh Annual Migraine and Headache Poetry Contest
9. Migraines Frequency Influences Heart Attack, Stroke Risk
10. Overuse of Opioids, Barbiturates Boosts Chronic Migraine Risk
11. Skin Pain, Sensitivity Rises With Migraine
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 2Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 3Health News:VHI Releases Annual Industry Report - Highlights Hospital, Nursing Facility Efficiency 2Health News:UPMC Health Plan Offers Brain Fitness Software to Improve Health 2Health News:UPMC Health Plan Offers Brain Fitness Software to Improve Health 3Health News:MassMutual Recognized as One of America's Healthiest Companies 2Health News:MassMutual Recognized as One of America's Healthiest Companies 3Health News:New research identifies modifiable risk factors for heart disease 2Health News:New research identifies modifiable risk factors for heart disease 3Health News:New research identifies modifiable risk factors for heart disease 4Health News:New research identifies modifiable risk factors for heart disease 5Health News:New research identifies modifiable risk factors for heart disease 6
[0] Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange[0] VHI Releases Annual Industry Report - Highlights Hospital, Nursing Facility Efficiency[0] UPMC Health Plan Offers Brain Fitness Software to Improve Health[0] MassMutual Recognized as One of America's Healthiest Companies[0] New research identifies modifiable risk factors for heart disease
Other Medicine News:Health News:AB 1019: It's Time for Big Alcohol to Pay Up 2Health News:Vince Papale and Eagles Fly for Leukemia Tee Up for a Cure at May 4, 2009 Celebrity Golf Classic and Auction 2Health News:Surgical education programs have demand for physician assistants and nurse practitioners 2Health News:AST Leaders Fly to Capitol Hill to Garner and Secure Support for Transplantation Initiatives 2Health News:Colgate-Palmolive Partners With Share Our Strength To Host Online Contest To Combat Childhood Hunger 2Health News:Colgate-Palmolive Partners With Share Our Strength To Host Online Contest To Combat Childhood Hunger 3Health News:Photos: Questions About Autism? The Brooklyn Autism Center Academy Can Help. 2Health News:Photos: Questions About Autism? The Brooklyn Autism Center Academy Can Help. 3
AB 1019: It's Time for Big Alcohol to Pay UpVince Papale and Eagles Fly for Leukemia Tee Up for a Cure at May 4, 2009 Celebrity Golf Classic and AuctionSurgical education programs have demand for physician assistants and nurse practitionersAST Leaders Fly to Capitol Hill to Garner and Secure Support for Transplantation InitiativesColgate-Palmolive Partners With Share Our Strength To Host Online Contest To Combat Childhood HungerPhotos: Questions About Autism? The Brooklyn Autism Center Academy Can Help.
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Debate on admin of magnesium sulfate to pregnant women to prevent cerebral palsy in pre term infants 9043 1Debate on admin of magnesium sulfate to pregnant women to prevent cerebral palsy in pre term infants 9043 2Female human embryos adjust the balance of X chromosomes before implantation 9041 1Female human embryos adjust the balance of X chromosomes before implantation 9041 2Female human embryos adjust the balance of X chromosomes before implantation 9041 3Female human embryos adjust the balance of X chromosomes before implantation 9041 4The National Council on Aging and CVS pharmacy Educate Pennsylvania Seniors on Medication Management and How to Save Money on Prescription Drugs 50279 1The National Council on Aging and CVS pharmacy Educate Pennsylvania Seniors on Medication Management and How to Save Money on Prescription Drugs 50279 2The National Council on Aging and CVS pharmacy Educate Pennsylvania Seniors on Medication Management and How to Save Money on Prescription Drugs 50279 3The National Council on Aging and CVS pharmacy Educate Pennsylvania Seniors on Medication Management and How to Save Money on Prescription Drugs 50279 4
[0] Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug[0] DecisionView Launches StudyOptimizer(TM) 4[0] Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign
Other Medicine Technology:New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA 2New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA 3New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA 4Syndicom SpineConnect Web Platform Chosen for Applied Spine's Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System 2Syndicom SpineConnect Web Platform Chosen for Applied Spine's Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |